40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.50%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-37.39%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-101.25%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-101.25%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-11.18%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.76%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.76%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.01%
Share reduction more than 1.5x MTDR's 0.15%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.01%
Diluted share reduction more than 1.5x MTDR's 0.28%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.01%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.76%
Similar OCF growth to MTDR's 68.98%. Walter Schloss would assume comparable operations or industry factors.
41.12%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
-88.22%
Negative 10Y revenue/share CAGR while MTDR stands at 430.49%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-36.46%
Negative 5Y CAGR while MTDR stands at 82.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-71.30%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-87.64%
Negative 10Y OCF/share CAGR while MTDR stands at 432.05%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-76.35%
Negative 5Y OCF/share CAGR while MTDR is at 93.66%. Joel Greenblatt would question the firm’s operational model or cost structure.
-60.94%
Negative 3Y OCF/share CAGR while MTDR stands at 10.65%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-75.90%
Negative 10Y net income/share CAGR while MTDR is at 126.82%. Joel Greenblatt sees a major red flag in long-term profit erosion.
117.88%
5Y net income/share CAGR at 50-75% of MTDR's 190.05%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-92.02%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-73.12%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-4.54%
Negative 5Y equity/share growth while MTDR is at 25.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-44.15%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-92.85%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.80%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-79.09%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-1.30%
Firm’s AR is declining while MTDR shows 29.30%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
1.03%
Asset growth well under 50% of MTDR's 4.02%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.67%
75-90% of MTDR's 3.00%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.48%
Debt growth far above MTDR's 0.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
23.91%
We expand SG&A while MTDR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.